Aspiriant LLC’s Xtrackers MSCI All World ex US Hedged Equity ETF DBAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-382,105
Closed -$9.69M 189
2016
Q2
$9.69M Buy
382,105
+317,840
+495% +$7M 0.92% 15
2016
Q1
$1.42M Buy
+64,265
New +$1.39M 0.14% 86

Other funds holding DBAW

Aspiriant LLC's DBAW Position: Q3 2016 in Review

Aspiriant LLC sold out of Xtrackers MSCI All World ex US Hedged Equity ETF (DBAW) in Q3 2016, closing a stake of 382,105 shares — an estimated $9.69M sold.

Aspiriant LLC first reported a position in DBAW in Q1 2016 and held it in 2 quarters. The position peaked at $9.69M in Q2 2016. 20 funds tracked by Wall St. Rank hold DBAW as of Q3 2016.

  • Aspiriant LLC reported no remaining Xtrackers MSCI All World ex US Hedged Equity ETF position as of Q3 2016 after selling out during the quarter.
  • Aspiriant LLC sold 382,105 Xtrackers MSCI All World ex US Hedged Equity ETF shares in Q3 2016, an estimated $9.69M.
  • Aspiriant LLC first reported a position in Xtrackers MSCI All World ex US Hedged Equity ETF in Q1 2016 and held it in 2 quarters.
  • Aspiriant LLC's Xtrackers MSCI All World ex US Hedged Equity ETF position peaked at $9.69M in Q2 2016.
  • 20 funds tracked by Wall St. Rank held Xtrackers MSCI All World ex US Hedged Equity ETF as of Q3 2016.

Based on Aspiriant LLC's 13F filing for Q3 2016, filed 10 Nov 2016.